Redwood City Newswire

Comprehensive Real-Time News Feed for Redwood City, CA.

Results 1 - 19 of 19 for "u:pr-inside.com" in Redwood City, CA

  1. Just Published: "Heron Therapeutics, Inc. (HRTX) - Pharmaceuticals &...Read the original story

    Sunday Jan 25 | PR-inside.com

    It uses its proprietary polymer-based drug delivery platform to improve the therapeutic profile of injectable pharmaceuticals. The company bases its products on the Biochronomer technology platform which can provide sustained levels of drugs for prolonged efficacy.The company's lead product is Sustol , is being developed to prevent chemotherapy-induced nausea and vomiting, or emesis in the treatment of cancer patients.

    Comment?

  2. Now Available: DreamWorks Animation SKG, Inc. (DWA) - Financial and Strategic SWOT Analysis ReviewRead the original story

    Wednesday Jan 14 | PR-inside.com

    DreamWorks Animation SKG, Inc. - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats.

    Comment?

  3. "AcelRx Pharmaceuticals, Inc. (ACRX) - Pharmaceuticals & Healthcare - ...Read the original story

    Sunday Jan 11 | PR-inside.com

    AcelRx Pharmaceuticals, Inc. is a pharmaceutical company. The company develops and markets therapies for the treatment of acute and breakthrough pain.

    Comment?

  4. Proteus Digital Health, Inc. - Medical Equipment - Deals and Alliances Profile - New Study ReleasedRead the original story

    Friday Jan 9 | PR-inside.com

    The company develops digital medicine for chronic diseases in-house and through partnership with the pharmaceutical, device and biotechnology companies. Its platform technologies include Proteus Digital Health Feedback System consisting of wearable and ingestible sensors, which detect ingestions and physiological data.

    Comment?

  5. iControl Networks, Inc. - Clean Technology - Deals and Alliances Profile - New Market ReportRead the original story

    Thursday Jan 1 | PR-inside.com

    The company offers software platform services. It offers cloud infrastructure, robustness and premise management services.

    Comment?

  6. Genomic Health: New Oncotype DXA Data Presented at 2014 San Antonio...Read the original story

    Dec 14, 2014 | PR-inside.com

    Genomic Health announced presentation of the first prospective outcomes data from a large adjuvant study with the Oncotype DX breast cancer test at the recent 2014 San Antonio Breast Cancer Symposium 1 . Early results from the Plan B study support the use of the Oncotype DX breast cancer test to optimise treatment recommendations based on individual patient risk.

    Comment?

  7. Coherus BioSciences to Present at the J.P. Morgan Healthcare Conference on January 12Read the original story

    Dec 8, 2014 | PR-inside.com

    REDWOOD CITY, Calif., Dec. 8, 2014 -- Coherus BioSciences, Inc. , a late-stage clinical biologics platform company focused on the global biosimilar market, today announced that it will present at the 33 Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015, at 9:30 a.m. PT at the Westin St. Francis Hotel in San Francisco, CA. A live and archived webcast of the presentation will be available on the Investor Relations page of the Coherus website at investors.coherus.com .

    Comment?

  8. Now Available: Pathwork Diagnostics - Medical Equipment - Deals and Alliances ProfileRead the original story

    Dec 7, 2014 | PR-inside.com

    The company develops and commercializes molecular diagnostics for oncology. Its pathwork tissue of origin test is a microarray-based gene expression test that helps in identifying tumors, including poorly differentiated, undifferentiated, and metastatic cancers.

    Comment?

  9. Coherus BioSciences to Host Earnings Conference Call on December 15Read the original story

    Dec 4, 2014 | PR-inside.com

    REDWOOD CITY, Calif., Dec. 4, 2014 -- Coherus BioSciences, Inc. , a late-stage clinical biologics platform company focused on the global biosimilar market, today announced that it has scheduled a conference call for Monday, December 15, 2014, at 1:30 p.m. PT / 4:30 p.m. ET to discuss its third quarter 2014 financial results and pipeline progress. Participating in the call will be Denny Lanfear, President and Chief Executive Officer, and Jean- Frederic Viret, Chief Financial Officer.

    Comment?

  10. YuMe Forms Exclusive Partnership with Vestel, Launches with Brand Campaign from O2Read the original story

    Nov 16, 2014 | PR-inside.com

    YuMe, Inc. , a leading provider of digital video brand advertising solutions, has struck an exclusive partnership with Vestel, one of the largest TV manufacturers in the world, and launched with a major branding campaign for O2, a leading UK digital communications company. The campaign debuts YuMe Captivate, a new ad unit designed specifically for Connected TV .

    Comment?

  11. New Market Report: Support.com, Inc. (SPRT) - Financial and Strategic SWOT Analysis ReviewRead the original story

    Nov 13, 2014 | PR-inside.com

    Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats.

    Comment?

  12. Coherus BioSciences Announces Closing of Initial Public Offering and...Read the original story

    Nov 12, 2014 | PR-inside.com

    REDWOOD CITY, Calif., Nov. 13, 2014 -- Coherus BioSciences, Inc. announced today the closing of its initial public offering of 6,803,702 shares of its common stock at a public offering price of $13.50 per share, before underwriting discounts, commissions and estimated expenses, which includes the purchase of 507,402 shares of Coherus common stock by the underwriters upon partial exercise of their option to purchase additional shares. All of the shares of common stock are being offered by Coherus.

    Comment?

  13. Coherus BioSciences Prices Initial Public Offering of $85 Million of Common StockRead the original story

    Nov 6, 2014 | PR-inside.com

    REDWOOD CITY, Calif., Nov. 6, 2014 -- Coherus BioSciences, Inc. announced today the pricing of its initial public offering of 6,296,300 shares of its common stock at a public offering price of $13.50 per share, before underwriting discounts, commissions and estimated expenses. All of the shares of common stock are being offered by Coherus.

    Comment?

  14. Jeffrey Gold Appointed Chief Executive Officer of myoscienceRead the original story

    Nov 3, 2014 | PR-inside.com

    REDWOOD CITY, Calif., Nov. 3, 2014 -- myoscience, inc. is pleased to announce the appointment of Jeffrey Gold as Chief Executive Officer effective immediately.

    Comment?

  15. New Market Research Report: Pulmonx Corporation - Medical Equipment - Deals and Alliances ProfileRead the original story

    Oct 30, 2014 | PR-inside.com

    The company develops and markets minimally invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders. It designs and manufactures products to deliver endoscopic lung volume reduction to patients with emphysema-induced hyperinflation.

    Comment?

  16. Pearl Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and...Read the original story

    Oct 20, 2014 | PR-inside.com

    The company develops the therapies for the treatment of highly prevalent chronic respiratory diseases, including chronic obstructive pulmonary disease and asthma. It offers product such as PT003, PT010, PT001, PT005 and PT002/PT009.

    Comment?

  17. Next Advancement for the iovera Beauty TreatmentRead the original story

    Sep 30, 2014 | PR-inside.com

    REDWOOD CITY, Calif., Oct. 1, 2014 -- California based myoscience, inc. announced today the newest advancement in the ioveraA beauty treatment for dynamic forehead wrinkles - the 1x55mm Round Smart Tip .

    Comment?

  18. New Market Research Report: Informatica Corporation (INFA) -...Read the original story

    Aug 31, 2014 | PR-inside.com

    The company is into Information Economics concentrating on Equipment Costs, Maintenance Costs, Service Costs and Software Licencing; Service Management with Helpdesk Management and Service Level Management; Consulting Services with Business and Strategy Consulting, Operations Consulting, and Technology and Transformation Consulting; Software ... (more)

    Comment?

  19. New Report Available: Heron Therapeutics, Inc. (HRTX) -...Read the original story

    Aug 16, 2014 | PR-inside.com

    It uses its proprietary polymer-based drug delivery platform to improve the therapeutic profile of injectable pharmaceuticals.

    Comment?

Redwood City Job Listings
View or post Redwood City job listings on Topix.
Redwood City Real Estate
News, listings, and foreclosures in Redwood City from Topix.
Redwood City Mortgages
Find mortgage rates in Redwood City on Topix.